Raloxifene halves invasive breast cancer risk: the selective estrogen receptor modulator was associated with same risk reduction as tamoxifen.(News)(Clinical ... An article from: Family Practice News
Book Details
Author(s)
Robert Finn
Publisher
Thomson Gale
ISBN / ASIN
B000GDH5WW
ISBN-13
978B000GDH5W7
Availability
Available for download now
Marketplace
United States 🇺🇸
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
This digital document is an article from Family Practice News, published by Thomson Gale on May 15, 2006. The length of the article is 809 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Raloxifene halves invasive breast cancer risk: the selective estrogen receptor modulator was associated with same risk reduction as tamoxifen.(News)(Clinical report)
Author: Robert Finn
Publication:Family Practice News (Magazine/Journal)
Date: May 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 10 Page: 4(1)
Article Type: Clinical report
Distributed by Thomson Gale
Citation Details
Title: Raloxifene halves invasive breast cancer risk: the selective estrogen receptor modulator was associated with same risk reduction as tamoxifen.(News)(Clinical report)
Author: Robert Finn
Publication:Family Practice News (Magazine/Journal)
Date: May 15, 2006
Publisher: Thomson Gale
Volume: 36 Issue: 10 Page: 4(1)
Article Type: Clinical report
Distributed by Thomson Gale
